Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
01/2008
01/08/2008CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists
01/08/2008CA2414311C Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
01/08/2008CA2410237C Adenosine a2a receptor antagonists
01/08/2008CA2402668C Use of cdp-choline for the prophylactic treatment of cerebral ischemia
01/08/2008CA2394027C New derivatives of octahydro-2h-pyrido[1,2-a] pyrazine, their preparation process and pharmaceutical compositions that contain them
01/08/2008CA2389170C A process for the production of epinastine hydrochloride in the high-melting crystal modification
01/08/2008CA2388716C Process for the purification of pharmacologically active proteins through cationic exchange chromatography
01/08/2008CA2335079C Composition for the treatement of immune deficiencies and methods for its preparation and use
01/08/2008CA2296031C Novel spiroazabicyclic heterocyclic compounds
01/08/2008CA2272720C New butyric esters with antiproliferative activity and the pharmaceutical compositions containing them
01/08/2008CA2228060C Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
01/08/2008CA2203901C Polymeric wound healing accelerators
01/08/2008CA2121716C Method and medical agent for diagnosis of arthritis
01/03/2008WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade
01/03/2008WO2008002514A2 Combination cough treatment compounds and method of treating common coughs
01/03/2008WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof
01/03/2008WO2008001956A1 Therapeutic agent for liver fibrosis
01/03/2008WO2008001930A1 Pyridylisoxazole derivative
01/03/2008WO2008001929A1 Treatment agent for inflammatory bowel disease
01/03/2008WO2008001912A1 Substituted benzyl ester derivative and use thereof
01/03/2008WO2008001886A1 Aurora inhibitor
01/03/2008WO2008001885A1 Abl KINASE INHIBITOR
01/03/2008WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT
01/03/2008WO2008001864A1 C-phenyl 1-thioglucitol compound
01/03/2008WO2008001778A1 Genetically modified animal and use thereof
01/03/2008WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin
01/03/2008WO2008001734A1 Compressed preparation
01/03/2008WO2008001502A1 Potentiator of radiation therapy
01/03/2008WO2008001491A1 Antiallergic agent
01/03/2008WO2008001101A2 Pharmaceutical combinations
01/03/2008US20080004613 Methods and devices for treatment of migraines
01/03/2008US20080004561 Method for Treating Oncological, Virulent and Somatic Diseases, Method for Controlling Treatment Efficiency, Pharmaceutical Agents and Composition for Carrying Out Said Treatment
01/03/2008US20080004435 Corticotropin releasing factor 2 receptor agonists
01/03/2008US20080004346 Methods and Compositions for Treatment of Intraepithelial Neoplasia
01/03/2008US20080004329 Pharmaceutical compositions of ropinirole and methods of use thereof
01/03/2008US20080004321 Potentiators of Glutamate Receptors
01/03/2008US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
01/03/2008US20080004300 protein kinase inhibitors such as N-[5-(4,4-Dimethyl-2,5-dioxo-3-pyridin-4-ylmethyl-imidazolidin-1-yl)-2-trifluoromethoxy-phenyl]-2-morpholin-4-yl-acetamide, used for treating tumors; antitumor and anticarcinogenic agents
01/03/2008US20080004294 Heterocyclic compounds
01/03/2008US20080004293 Adenosine receptor antagonists and methods of making and using the same
01/03/2008US20080004287 Human Double Minute 2 (HDM2) protein inhibitors; anticancer agents
01/03/2008US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors
01/03/2008US20080004247 Combinations of Statins with Bronchodilators
01/03/2008US20080004236 High Dose, Short Interval Use of Sulfated Polysaccharides for Treatment of Infections
01/03/2008US20080004230 SAM Riboswitch and Uses Thereof
01/03/2008US20080004228 New Expression Tools for Multiprotein Applications
01/03/2008US20080004227 Pharmaceutical Composition for Lowering Blood Sugar Level
01/03/2008US20080004208 Methods for Diagnosis and Prognosis of Malignant Lymphoma
01/03/2008US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories
01/03/2008US20080003675 Methods and compositions for identifying morphogen analogs
01/03/2008US20080003311 Rosmarinus extracts for inhibiting/treating skin aging
01/03/2008US20080003304 Combination chemotherapy
01/03/2008US20080003303 Nutraceutical treatments for diabetic and non-diabetic wound healing
01/03/2008US20080003302 Method And Nutraceutical Composition For Mammals
01/03/2008US20080003297 Taste-masking oral dosage form and method of preparing the same
01/03/2008US20080003294 Methods for pulmonary delivery of interleukin-2
01/03/2008US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases
01/03/2008US20080003283 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
01/03/2008US20080003280 Combination cough treatment compounds and method of treating common coughs
01/03/2008US20080003258 Composition and Method for Treating Rheumatoid Arthritis
01/03/2008US20080003257 Composition and Method for Treating Connective Tissue Damage
01/03/2008US20080003243 Oral Anti-Protozoiasis Vaccines Based on Transgenic Plants
01/03/2008US20080003239 Yeast-based Vaccine for Inducing an Immune Response
01/03/2008US20080003237 Gram Positive Bacterial Cells Comprising a Disrupted Flagellin Gene, Flagellin-Based Fusion Proteins and Use in Removal of Metal Ions from a Liquid
01/03/2008US20080003236 Adenovirus fiber shaft composition and methods of use
01/03/2008US20080003226 Method to Reduce Hepatoxicity of Fas-Mediated Apoptosis-Inducing Agents
01/03/2008US20080003206 ABCB5 positive mesenchymal stem cells as immunomodulators
01/03/2008US20080003204 Compositions and methods for treating cystic fibrosis
01/03/2008US20080003201 Interleukin-12 as a veterinary vaccine adjuvant
01/03/2008US20080003198 Hernia treatment agents
01/03/2008US20080003186 Material for inhibiting enamel demineralization
01/03/2008CA2656165A1 Bicyclic compositions and methods for modulating a kinase cascade
01/03/2008CA2656159A1 Pyridylisoxazole derivatives
01/03/2008CA2655999A1 Treating agent of inflammatory bowel disease
01/03/2008CA2655937A1 C-phenyl 1-thioglucitol compound
01/03/2008CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility
01/03/2008CA2652811A1 Potentiator of radiation therapy
01/02/2008EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs
01/02/2008EP1873154A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVE OR MEDICALLY ACCEPTABLE SALT THEREOF
01/02/2008EP1873148A1 pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
01/02/2008EP1873144A1 Fused heterocyclic compound
01/02/2008EP1872797A2 Treatment of cardiovascular and related pathologies
01/02/2008EP1872785A1 pharmaceutical composition comprising condensed indole compound
01/02/2008EP1872780A2 Omega-Phenyloctanamides as therapeutic compounds
01/02/2008EP1651201B1 Necrosis avid tracer agent
01/02/2008EP1465614B1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
01/02/2008EP1448223B1 Thymosin augmentation of genetic immunization
01/02/2008EP1443942B1 Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonate, a cox-2 inhibitor and a taxol
01/02/2008EP1435986B1 Igf-binding protein-derived peptide
01/02/2008EP1416933B1 Substituted piperidines as modulators of the melanocortin receptor
01/02/2008EP1414797B1 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
01/02/2008EP1414441B1 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
01/02/2008EP1406859B1 Substituted 4-aminocyclohexanol derivatives
01/02/2008EP1391198B1 Novel sphingolipid synthesis inhibitor
01/02/2008EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
01/02/2008EP1272161B1 Lipid-based drug delivery systems against parasitic infections
01/02/2008EP1263739B1 Crystalline salts of 7-¬4-(4-fluorophenyl)-6-isopropyl-2-¬methyl(methylsulfonyl)amino pyrimidin-5-yl -(3r,5s)-3,5-dihydroxyhept-6-enoic acid
01/02/2008EP1121116B1 Sustained release pharmaceutical composition of fluvastatin
01/02/2008EP0988044B1 Water/ethanol centipeda cunninghamii plant extract
01/02/2008CN101098894A High-molecular fucoidan, method of producing the same and cosmetic composition